The largest single cell study to date of the childhood cancer, neuroblastoma, has discovered that all neuroblastomas arise from a single...

Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting...

Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a...

A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results ...

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been ...

The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially...

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by...

Researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to...

As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key,...

T1 mapping has the potential to determine neuroblastoma aggressiveness, as well as early efficacy of treatment. Read more:...